The 32 references in paper Yu. Selikhova B., I. Ostanina B., N. Starostina M., S. Sidorov V., E. Menyaeva V., V. Kozhevnikov S., E. Chernykh R., A. Ostanin A., V. Kozlov A., Ю. Селихова Б., И. Останина Б., Н. Старостина М., С. Сидоров В., Е. Меняева В., В. Кожевников С., Е. Черных Р., А. Останин А., В. Козлов А. (2014) “ПАРАМЕТРЫ ИММУНИТЕТА У БОЛЬНЫХ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ ПОСЛЕ ЛУЧЕВОЙ ТЕРАПИИ И ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ // IMMUNE PARAMETERS IN PATIENTS WITH BREAST CANCER AFTER RADIOTHERAPY AND SURGICAL TREATMENT” / spz:neicon:mimmun:y:2007:i:5:p:418-428

1
Антонов В.Г., Козлов В.К. Патогенез онкологических заболеваний: иммунные и биохимические феномены и механизмы. Внеклеточные и клеточные механизмы общей иммунодепрессии и иммунной резистентности // Цитокины и воспаление. – 2004. – Т. 3, No 1. – С. 8-19.
(check this in PDF content)
2
Зотов А.С., Белик Е.О. Мастопатии и рак молочной железы. – М.: МЕДпресс-информ, 2005. – 112 с.
(check this in PDF content)
3
Козлов В.А. Некоторые аспекты проблемы цитокинов // Цитокины и воспаление. – 2002. – Т. 1, No 1. – С. 5-8.
(check this in PDF content)
4
Козлов В.А. Гранулоцитарный колониестимулирующий фактор: физиологическая активность, патофизиологические и терапевтические проблемы // Цитокины и воспаление. – 2004. – Т. 3, No 2. – С. 3-15.
(check this in PDF content)
5
Летягин В.П. Первичные опухоли молочной железы. – М.: Миклош, 2004. – 332 с.
(check this in PDF content)
6
Останин А.А., Черных Е.Р. Сравнительная оценка уровня 17 цитокинов в сыворотке и цельной крови здоровых доноров методом проточной флюориметрии // Цитокины и воспаление. – 2005. – Т. 2, No 2. – С. 25-32.
(check this in PDF content)
7
Ярилин А.А. Гомеостатические процессы в иммунной системе. Контроль численности лимфоцитов // Иммунология. – 2004. – No 5. – С. 312-320.
(check this in PDF content)
8
Adams D.H., Harvath L., Bottaro D.P., Interrante R., Catalano G., Tanaka Y., Strain A., Hubscher S.G., Shaw S. Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T-cells // Proc. Natl. Acad. Sci. USA. – 1994. – Vol. 91, N 15. – P. 7144-7148.
(check this in PDF content)
9
Asavaroengchai W., Kotera Y., Mule J.J. Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery // Proc. Natl. Acad. Sci. USA. – 2002. – Vol. 99, N 2. – P. 931-936.
(check this in PDF content)
10
Bolotin E., Annett G., Parkman R., Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count // Bone Marrow Transplant. – 1999. – Vol. 23. – P. 783-788.
(check this in PDF content)
11
Bosco N., Agenes F., Ceredig R. Effects of increasing IL-7 availability on lymphocytes during and after lymphopenia-induced proliferation // J. Immunol. – 2005. – Vol. 175. – P. 162-170.
(check this in PDF content)
12
Bourgeois C., Stockinger B. CD25+CD4+ regulatory T-cells and memory T-cells prevent lymphopenia- induced proliferation of naive T-cells in transient states of lymphopenia // J. Immunol. – 2006. – Vol. 177. – P. 4558-4566.
(check this in PDF content)
13
Cho B.K., Rao V.P., Ge Q., Eisen H.N., Chen J. Homeostasis-stimulated proliferation drives naive Tcells to differentiate directly into memory T-cells // J. Exp. Med. – 2000. – Vol. 192. – P. 549-556.
(check this in PDF content)
14
Dummer W., Niethammer A.G., Baccala R., Lawson B.R., Wagner N., Reisfeld R.A., Theofilopoulos A.N. T-cell homeostatic proliferation elicits effective antitumor autoimmunity // J. Clin. Invest. – 2002. – Vol. 110, N 2. – P. 185-192.
(check this in PDF content)
15
Ende N., Schwartz R.A. Autoimmunity and AIDS. A commentary // J. Exp. Med. – 1997. – Vol. 28. – P. 273-274.
(check this in PDF content)
16
Fry T.J., Mackall C.L. The many faces of IL7: from lymphopoiesis to peripheral T-cell maintenance // J. Immunol. – 2005. – Vol. 174. – P. 6571-6576.
(check this in PDF content)
17
Ge Q., Palliser D., Eisen H.N., Chen J. Homeostatic T-cell proliferation in a T-cell-dendritic cell coculture system // Proc. Natl. Acad. Sci. USA. – 2002. – Vol. 99. – P. 2983-2988.
(check this in PDF content)
18
Goldrath A.W., Luckey C.J., Park R., Benoist C., Mathis D. The molecular program induced in T-cells undergoing homeostatic proliferation // Proc. Natl. Acad. Sci. USA. – 2004. – Vol. 101. – P. 16885-16890.
(check this in PDF content)
19
Goldrath A.W., Sivakumar P.V. Glaccum M., Kennedy M.K., Bevan M.J., Benoist C., Mathis D., Butz E.A. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8 T-cells // J. Exp. Med. – 2002. – Vol. 195, N 12. – P. 1515-1522.
(check this in PDF content)
20
Guimond M., Fry T.J., Mackall C.L. Cytokine signals in T-cell homeostasis // J. Immunother. – 2005. – Vol. 28, N 4. – P. 289-294.
(check this in PDF content)
21
Hofseth L.J., Wargovich M.J. Inflammation, cancer, and targets of ginseng // J. Nutr. – 2007. – Vol. 137, N 1. – P. 183-185.
(check this in PDF content)
22
Hu H.M., Poehlein C.H., Urba W.J., Fox B.A. Development of antitumor immune responses in reconstituted lymphopenic hosts // Cancer Res. – 2002. – Vol. 62. – P. 3914-3919.
(check this in PDF content)
23
Koetz K., Bryl E., Spickschen K., O’Fallon M.W., Goronzy J.J., Weyand C.M. T-cell homeostasis in patients with rheumatoid arthritis // Proc. Natl. Acad. Sci. USA. – 2000. – Vol. 97. – P. 9203-9208.
(check this in PDF content)
24
Krupica T.Jr., Fry T.J., Mackall C.L. Autoimmunity during lymphopenia: a two-hit model // Clin. Immunol. – 2006. – Vol. 120, N 2. – P. 121-128.
(check this in PDF content)
25
Mastroianni C.M., Forcina G., d’Ettorre G., Lichtner M., Mengoni F., D’Agostino C., Vullo V. Circulating levels of interleukin-7 in antiretroviralnaive and highly active antiretroviral therapy-treated HIV-infected patients // HIV Clin. Trials. – 2001. – Vol. 2. – P. 108-112.
(check this in PDF content)
26
Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., Herndier B.G., Andersson J., McCune J.M. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis // Nat. Med. – 2001. – Vol. 7. – P. 73-79.
(check this in PDF content)
27
Seddon B., Zamoyska R. TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T-cells // J. Immunol. – 2002. – Vol. 169. – P. 37523759.
(check this in PDF content)
28
Shimizu K., Fields R.C., Giedlin M., Mule J.J. Systemic administration of interleukin-2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines // Proc. Natl. Acad. Sci. USA. – 1999. – Vol. 96. – P. 2268–2273.
(check this in PDF content)
29
Theofilopoulos A.N., Dummer W., Kono D.H. T-cell homeostasis and systemic autoimmunity // J. Clin. Invest. – 2001. – Vol. 108, N 3. – P. 335-340.
(check this in PDF content)
30
Wang L-X., Li R., Yang G., Lim M., O’Hara A., Chu Y., Fox B.A., Restifo N.P., Urba W.J., Hu H-M. Interleukin-7-dependent expansion and persistence of melanoma-specific T-cells in lymphodepleted mice lead to tumor regression and editing // Cancer Res. – 2005. – Vol. 65. – P. 10569-10577.
(check this in PDF content)
31
Wang L-X., Shu S., Plautz G.E. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells // Cancer Res. – 2005. – Vol. 65. – P. 9547-9554.
(check this in PDF content)
32
Yagoob P., Newsholme E.A., Calder P.C. Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells // Cytokine. – 1999. – Vol. 11, N 8. – P. 600-605. поступила в редакцию 02.02.2007
(check this in PDF content)